Printer Friendly

TOPOX TO CHANGE NAME

 TOPOX TO CHANGE NAME
 CHADDS FORD, Pa., Oct. 22 /PRNewswire/ -- Stockholders at the


Oct. 16 annual meeting of Topox, Inc. (AMEX: TPO.EC) approved the change of the company's name to Supra Medical Corp.
 The new ticker symbol will be SUM.EC. The corporate name change and change in ticker symbol will be effective as of the commencement of trading on Monday, Oct. 26.
 Jack Cantwell, chairman of the board and chief executive officer, said, "For some time, we have recognized that the Topox name had limitations. With the constant broadening of our products and services, the name put inordinate focus on our hyperbaric oxygen chambers at the expense of all other activities. In addition to correcting this imbalance, we will now be able to use the 'supra' prefix to better identify and market individual lines under a shared corporate identity."
 Evelyna Dyson Cantwell, president, said, "The name change will also be a boon to our research efforts because the scientific community will no longer be confused by the contrast between the Topox name and our ultrasound work."
 In addition to re-electing the four incumbent directors of the company, stockholders also elected three new directors to the company's board: Dr. Mary Dyson, who is the director of the Tissue Repair Research Unit, United Medical and Dental Schools of Guy's and St. Thomas's Hospitals, London; Margaret M. Heckler, who served as secretary of Health and Human Services in the Reagan cabinet; and George J. Stasen, who created the first medical sector mutual fund, Medical Technology Fund, and its companion, Emerging Medical Technology Fund.
 Supra Medical Corp. develops and markets proprietary medical products which are used in the diagnosis, monitoring and ongoing treatment of skin disorders such as wounds, ulcerations, burns and other skin disorders including skin cancers and melanomas.
 /delval/
 -0- 10/22/92
 /CONTACT: George J. Stasen, chief operating officer and executive vice president of Supra Medical Corp., 800-388-6769/
 (TPO SUM) CO: Topox, Inc.; Supra Medical Corp. ST: Pennsylvania IN: HEA SU: PER


MJ-LJ -- PH042 -- 3779 10/22/92 15:33 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 22, 1992
Words:342
Previous Article:POE & ASSOCIATES, INC. ANNOUNCES QUARTERLY CASH DIVIDEND
Next Article:ASPEN MARINE GROUP SECURES ONE YEAR INTERIM PRIVATE FINANCING PACKAGE
Topics:


Related Articles
TOPOX ANNOUNCES COMPLETION OF RECENT PRIVATE PLACEMENT AND ACCEPTANCE TO LIST ON EMERGING COMPANY MARKETPLACE
TOPOX ISSUES ANNOUNCEMENTS
GEORGE J. STASEN JOINS TOPOX AS EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER
TOPOX REPORTS RESULTS FOR FISCAL YEAR ENDED MARCH 31, 1992
TOPOX ANNOUNCES RESULTS FOR THE FIRST QUARTER ENDED JUNE 30, 1992
TOPOX ANNOUNCES THE FDA HAS RULED FAVORABLY ON ITS 510K APPLICATION
TOPOX AND APPLIED BIOSENSORS TO DEVELOP SKIN TISSUE MONITORING SYSTEM
TOPOX: AGREEMENT SIGNED TO MANUFACTURE INNOVATIVE MEDICAL DEVICES
TOPOX TO CHANGE NAME
NASA PROJECT TO FURTHER ULTRASOUND DIAGNOSTIC FRONTIERS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters